Evaluating the implementation of the RACE-instrument in asthma and COPD patients with inhaled maintenance therapy

Evaluating the implementation of the 'Respiratory Adherence Care Enhancer' (RACE) instrument with complex multidimensional interventions to improve self-management, reach treatment goals and disease stability in asthma and Chronic Obstructive Pulmonary Disease (COPD) patients using inhaled maintenance therapy: an exploratory randomized controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29180

Enrollment

400

Registered

2021-10-02

Start date

2021-10-17

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma and COPD

Interventions

The intervention consists of personal support and tailored care provided by community pharmacists with the RACE-instrument and its complex multidimensional interventions in consultations with asthma p

Eligibility

Inclusion criteria

Inclusion criteria: - = 18 years of age - Being treated for asthma with ICS maintenance therapy or - Being treated for COPD with LAMA or LABA according to dispensing data for these conditions present in the pharmacy information systems. - Able to answer to online questionnaires

Exclusion criteria

Exclusion criteria: - Concomitant asthma and COPD, suspicions hereof or diagnosed with other significant lung diseases from information present in the pharmacy - Incapability to speak, write and comprehend the Dutch language - Presence of any cognitive impairments

Design outcomes

Primary

Measure	Time frame
The primary objective is to evaluate the feasibility and acceptability of the RACE-instrument with complex multidimensional interventions provided in consultations by community pharmacists in asthma and COPD patients with maintenance inhaler therapy.	—

Secondary

Measure	Time frame
As secondary objective the effectiveness of personal support and tailored care provided with the RACE-instrument and its complex multidimensional interventions by community pharmacists is compared between IG and CG patients regarding number of barriers to self-management with inhaled maintenance therapy, the achievement of personal goals and disease stability.	—

Contacts

Public ContactMartina Teichert

Leiden University Medical Center

M.Teichert@lumc.nl+31-(0)71 5262790

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)